Surgery is more cost-effective than splinting for carpal tunnel syndrome in the Netherlands: Results of an economic evaluation alongside a randomized controlled trial

BMC Musculoskeletal Disorders

Volumn 7, Issue , 2006, Pages

  Korthals De Bos, Ingeborg B C ^a   Gerritsen, Annette A M ^a   Van Tulder, Maurits W ^a,b   Rutten Van Mölken, Maureen P M H ^c   Adèr, Herman J ^a   De Vet, Henrica C W ^a   Bouter, Lex M ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b VU UNIVERSITY AMSTERDAM   (Netherlands)

^c ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CARPAL TUNNEL SYNDROME; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; COST UTILITY ANALYSIS; ECONOMIC EVALUATION; HEALTH CARE COST; HEALTH CARE SYSTEM; HUMAN; MAJOR CLINICAL STUDY; NETHERLANDS; SPLINTING; TREATMENT OUTCOME;

CARPAL TUNNEL SYNDROME; COST-BENEFIT ANALYSIS; HEALTH CARE COSTS; HEALTH RESOURCES; HUMANS; NETHERLANDS; ORTHOPEDIC PROCEDURES; SPLINTS; TREATMENT OUTCOME;

EID: 33751329977     PISSN: 14712474     EISSN: 14712474     Source Type: Journal    
DOI: 10.1186/1471-2474-7-86     Document Type: Article

References (23)

1. Krom de MC, Knipschild PG, Kester AD, Thijs CT, Boekkooi PF, Spaans F: Carpal tunnel syndrome: prevalence in the general population. J Clin Epidemiol 1992, 45:373-6.
2. Atroshi I, Gummesson C, Johnsson R, Ornstein E, Ranstam J, Rosen I: Prevalence of carpal tunnel syndrome in a general population. JAMA 1999, 282:153-8.
3. Gerritsen AA, Uitdehaag BM, van Geldere D, Scholten RJ, de Vet HC, Bouter LM: Surgical treatment options for carpal tunnel syndrome: a systematic review of randomised controlled trials. Br J Surg 2001, 88:1285-95.
4. O'Connor D, Marshall S, Massy-Westropp N: Non-surgical treatment (other than steroid injection) for carpal tunnel syndrome. In Cochrane Library Issue 1 Oxford: Update Software; 2003.
5. Marshall S, Tardif G, Ashworth N: Local corticosteroid injections for carpal tunnel syndrome. In Cochrane Library Issue 4 Oxford: Update Software; 2002.
6. Goodyear-Smith F, Arroll B: What can family physicians offer patients with carpal tunnel syndrome other than surgery? A systematic review of nonsurgical management. Ann Fam Med 2004, 2:267-73.
7. Muller M, Tsui D, Schnurr R, Biddulph-Deisroth L, Hard J, MacDermid JC: Effectiveness of hand therapy interventions in primary management of carpal tunnel syndrome: a systematic review. J Hand Ther 2004, 17:210-28.
8. Verdugo RJ, Salinas RS, Castillo J, Cea JG: Surgical versus non-surgical treatment for carpal tunnel syndrome. In Cochrane Library Issue 1 Oxford: Update Software; 2003.
9. Ly-Pen D, Andreu JL, de Blas G, Sanchez-Olaso A, Millan I: Surgical decompression versus local steroid injection in carpal tunnel syndrome: a one-year, prospective, randomized, open, controlled clinical trial. Arthritis Rheum 2005, 52:612-9.
10. Hui AC, Wong S, Leung CH, Tong P, Mok V, Poon D, Li-Tsang CW, Wong LK, Boet R: A randomized controlled trial of surgery vs steroid injection for carpal tunnel syndrome. Neurology 2005, 64:2074-8.
11. Gerritsen AA, de Vet HC, Scholten RJ, Bertelsmann FW, de Krom MC, Bouter LM: Splinting or surgery for carpal tunnel syndrome: a randomized controlled trial. JAMA 2002, 288:1245-51.
12. Gerritsen AA, Scholten RJ, Assendelft WJ, Kuiper H, de Vet HC, Bouter LM: Splinting or surgery for carpal tunnel syndrome? BMC Neurol 2001, 1:18.
13. Dolan P: Modelling valuations for EuroQol health states. Med Care 1997, 35:1095-108.
14. Goossens ME, Rutten-van Mölken MP, Vlaeyen JW, van der Linden SM: The cost diary: a method to measure direct and indirect costs in cost-effectiveness research. J Clin Epidemiol 2000, 53:688-95.
15. Oostenbrink JB, Koopmanschap MA, Rutten FF: Handbook for cost studies, methods and guidelines for economic evaluation in health care [In Dutch: Handleiding voor kostenonderzoek, methoden en richtlijnprijzen voor economische evaluaties in de gezondheidszorg]. Health Care Insurance Council 2000.
16. Oostenbrink JB, Koopmanschap MA, Rutten FF: Standardisation of costs: the Dutch manual for costing in economic evaluatoins. Pharmacoeconomics 2002, 20:443-54.
17. COTG: Dutch Central Organisation for Health Care Charges. Tariffs for medical specialist, excluding psychiatrists. Supplement to tariffs decision number 5600-1900-97-1 from 21 oktober 1996. In [In Dutch: Tarieven voor medische specialisten, exclusief psychiaters. Bijlage bij tariefbeschikking, nummer 5600-1900-97-1] Dutch Central Organization for Health Care Charges, Utrecht; 1996.
18. Taxe Report. Z-index. [In Dutch] The Hague 2000.
19. Efron B, Tibshirani RJ: An introduction to the bootstrap New York London: Chapman & Hall; 1993.
20. Chaudhary MA, Stearns SC: Estimating confidence intervals for cost-effectiveness ratios: an example from a randomized trial. Stat Med 1996, 15:1447-58.
21. van Hout BA, Al MJ, Gordon GS, Rutten FF: Cost, effects and c/e ratios alongside a clinical trial. Health Econ 1994, 3:309-19.
22. Koopmanschap MA, Rutten FF: A practical guide for calculating indirect costs of disease. Phamacoeconomics 1996, 10:460-6.
23. American Academy of Neurology (AAN): Practice parameter for carpal tunnel syndrome (summary statement). Report of the quality Standards Subcommittee of the American Academy of Neurology. Neurology 1993, 43:2406-9.